Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...

Cantor Fitzgerald adjusted its price target for Teradyne stock (NASDAQ:TER), bringing it down to $150 from the previous $160, while still maintaining an Overweight rating on the company's shares.

Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (NasdaqGS:LRCX) from ...

Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Datadog in a research ...

Cantor Fitzgerald assumed coverage of Cidara Therapeutics (CDTX) with an Overweight rating. Cidara’s lead asset CD388, an anti-viral that ...

Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...

Cantor Fitzgerald analyst Jonathan Ruykhaver reiterated a Hold rating on Check Point (CHKP – Research Report) today and set a price target of $200.00. The company’s shares closed last Friday ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...

On Wednesday, Cantor Fitzgerald adjusted its price outlook for Meta Platforms Inc. shares (NASDAQ: NASDAQ:META), setting the new target at $720, a slight decrease from the previous $730 ...